NCT01304043View on ClinicalTrials.gov

French Observatory of Rare Malignant Tumors of the Ovary

CompletedOBSERVATIONAL
Enrollment

204

Participants

Timeline

Start Date

January 31, 2002

Study Completion Date

June 30, 2011

Conditions
Ovarian Tumors
Interventions
DRUG

chemotherapies protocols

Cisplatine 20 mg/m² IV Etoposide 100 mg/m² IV Bléomycine 30 mg IV

Trial Locations (1)

75004

Oncologie, Hôtel-Dieu, 1 place du parvis Notre-Dame, Paris

All Listed Sponsors
lead

ARCAGY/ GINECO GROUP

OTHER

NCT01304043 - French Observatory of Rare Malignant Tumors of the Ovary | Biotech Hunter | Biotech Hunter